as 04-23-2025 4:00pm EST
Founded: | 2018 | Country: | United States |
Employees: | N/A | City: | BOSTON |
Market Cap: | N/A | IPO Year: | 2021 |
Target Price: | $9.20 | AVG Volume (30 days): | 540.5K |
Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.32 | EPS Growth: | N/A |
52 Week Low/High: | $0.83 - $5.39 | Next Earning Date: | 05-13-2025 |
Revenue: | $16,146,000 | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
PYXS Breaking Stock News: Dive into PYXS Ticker-Specific Updates for Smart Investing
GlobeNewswire
22 days ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
Simply Wall St.
2 months ago
GlobeNewswire
3 months ago
TipRanks
4 months ago
The information presented on this page, "PYXS Pyxis Oncology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.